Patent details
EP3884947 Title: INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY
Basic Information
- Publication number:
- EP3884947
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP211523147
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY
- French Title of Invention:
- AUGMENTATION DE LA BIODISPONIBILITÉ PHARMACOLOGIQUE D'UN TRAITEMENT À BASE DE NALTREXONE
- German Title of Invention:
- ERHÖHUNG DER BIOVERFÜGBARKEIT VON HEILMITTELN IN EINER NALTREXONTHERAPIE
- SPC Number:
Dates
- Filing date:
- 02/12/2011
- Grant date:
- 15/11/2023
- EP Publication Date:
- 29/09/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/11/2023
- EP B1 Publication Date:
- 15/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 02/12/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/11/2023
- Name:
- Nalpropion Pharmaceuticals LLC
- Address:
- 155 Franklin Rd, Suite 450, Brentwood, TN 37027, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 15/01/2024
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- DUNAYEVICH,, Eduardo
- Address:
- United States (US)
2
- Name:
- FLANAGAN,, Shawn
- Address:
- United States (US)
Priority
- Priority Number:
- 41939510 P
- Priority Date:
- 03/12/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/485; A61K 31/137; A61P 3/04; A61K 45/06;
Publication
European Patent Bulletin
1
- Issue number:
- 202346
- Publication date:
- 15/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202351
- Publication date:
- 20/12/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 16
- Annual Fee Amount:
- 230 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 28/11/2025
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 213 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 15/01/2024 | Power Of Attorney | 1 |
| 16/01/2024 | Outgoing Correspondence | 1 |